RMP V03 Oct14 - HPRA · After-dilution; Paracetamol B. Braun can be diluted in 9 mg/ml (0.9%)...

1
RMP V03_Oct14

Transcript of RMP V03 Oct14 - HPRA · After-dilution; Paracetamol B. Braun can be diluted in 9 mg/ml (0.9%)...

Page 1: RMP V03 Oct14 - HPRA · After-dilution; Paracetamol B. Braun can be diluted in 9 mg/ml (0.9%) sodium chloride solution for infusion or 50 mg/ml (5%) glucose solution for infusion

RMP V03_Oct14

ANNEX I LIST OF THE NAMES, PHARMACEUTICAL · PDF fileCiprofloxacin ANTIBAC 500 mg film-coated tablets oral use 500 mg . 5 ... Ciprofloxacin BAYER 100 mg/50 ml solution for infusion

ANNEX I LIST OF THE NAMES, PHARMACEUTICAL · PDF fileCiprofloxacin ANTIBAC 500 mg film-coated tablets oral use 500 mg . 5 ... Ciprofloxacin BAYER 100 mg/50 ml solution for infusion

DATA SHEET - MedsafeOPDIVO V16.0 1 DATA SHEET 1 PRODUCT NAME OPDIVO 10 mg/mL concentrate for solution for infusion. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 mL of concentrate

DATA SHEET - MedsafeOPDIVO V16.0 1 DATA SHEET 1 PRODUCT NAME OPDIVO 10 mg/mL concentrate for solution for infusion. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 mL of concentrate

Symbiotic Human Gut Bacteria with Variable Metabolic ... · 1.0 0.8 0.6 0.4 0.2 0 0 500 1000 1500 2000 2500 3000 8 mg/ml PMOG 1 mg/ml levan 6 mg/ml PMOG 2 mg/ml levan 4 mg/ml PMOG

Symbiotic Human Gut Bacteria with Variable Metabolic ... · 1.0 0.8 0.6 0.4 0.2 0 0 500 1000 1500 2000 2500 3000 8 mg/ml PMOG 1 mg/ml levan 6 mg/ml PMOG 2 mg/ml levan 4 mg/ml PMOG

CIPROFLOXACIN 2MG/ML INFUSION PL 20568/0003 · PDF fileMHRA PAR – Ciprofloxacin 2mg/ml Infusion PL 20568/0003 - 1

CIPROFLOXACIN 2MG/ML INFUSION PL 20568/0003 · PDF fileMHRA PAR – Ciprofloxacin 2mg/ml Infusion PL 20568/0003 - 1

Weebly...4. 1 g = 1,000 mg 4 ml 2,000 mg/8 ml 2000 mg 250 mg/ml reduce 5. 2 g = 2,000 mg 8 ml EXAMPLE You add 18 ml of sterile water for injection to a vial containing 500 mg of a

Weebly...4. 1 g = 1,000 mg 4 ml 2,000 mg/8 ml 2000 mg 250 mg/ml reduce 5. 2 g = 2,000 mg 8 ml EXAMPLE You add 18 ml of sterile water for injection to a vial containing 500 mg of a

Public Assessment Report Decentralised Procedure … · Public Assessment Report . Decentralised Procedure . Linezolid 2 mg/ml solution for infusion . Linezolid 600mg film coated

Public Assessment Report Decentralised Procedure … · Public Assessment Report . Decentralised Procedure . Linezolid 2 mg/ml solution for infusion . Linezolid 600mg film coated

Reference ID: 3875027Previously Untreated CLL and Extended Treatment in CLL: • For initial 300-mg dose: Initiate infusion at a rate of 3.6 mg/hour (12 mL/hour). • For subsequent

Reference ID: 3875027Previously Untreated CLL and Extended Treatment in CLL: • For initial 300-mg dose: Initiate infusion at a rate of 3.6 mg/hour (12 mL/hour). • For subsequent

HETEROGENEOUS SODİUM DEATUNGSTATE ATALYSTS FOR …€¦ · Propranolol b-BLOCKER 361.4 253.3 290.3 363.3 266.3 1.44 mg/mL 0.459 mg/mL 0.615 mg/mL 0.152 mg/mL 0.0794 mg/mL 5.4 5.6

HETEROGENEOUS SODİUM DEATUNGSTATE ATALYSTS FOR …€¦ · Propranolol b-BLOCKER 361.4 253.3 290.3 363.3 266.3 1.44 mg/mL 0.459 mg/mL 0.615 mg/mL 0.152 mg/mL 0.0794 mg/mL 5.4 5.6

Beyond Genetics - PHARMAQO LABS · Injection Steroids 400 mg./ml. 10 ml. vial. 150 mg./ml. 10 ml. vial. 400 mg./ml. 10 ml. vial. 10 ml. vial. Visit our website for more products and

Beyond Genetics - PHARMAQO LABS · Injection Steroids 400 mg./ml. 10 ml. vial. 150 mg./ml. 10 ml. vial. 400 mg./ml. 10 ml. vial. 10 ml. vial. Visit our website for more products and

E-ISSN: In-vitro anticancer activity of petroleum ether ... · petroleum ether extracts (0.078 mg/ml, 0.156 mg/ml, 0.312 mg/ml, 0.625, 1.25 mg/ml, 2.5 mg/ml, 5 mg/ml, 10 mg/ml) were

E-ISSN: In-vitro anticancer activity of petroleum ether ... · petroleum ether extracts (0.078 mg/ml, 0.156 mg/ml, 0.312 mg/ml, 0.625, 1.25 mg/ml, 2.5 mg/ml, 5 mg/ml, 10 mg/ml) were

PATIENT INFORMATION PRESCRIBER INFORMATION · Psoriasis 80 mg/0.8 mL and 40 mg/0.4 mL Quantity: 1 Package Humira Hidradenitis Suppurativa 80 mg/0.8 mL Humira 40 mg/0.4 mL Pen 40 mg/0.4

PATIENT INFORMATION PRESCRIBER INFORMATION · Psoriasis 80 mg/0.8 mL and 40 mg/0.4 mL Quantity: 1 Package Humira Hidradenitis Suppurativa 80 mg/0.8 mL Humira 40 mg/0.4 mL Pen 40 mg/0.4

SINTESIS PROTEIN MIKROBA DAN AKTIVITAS ...sampai terendah yaitu T2 (59,50 mg/ml), T3 (55,58 mg/ml), T4 (47,55 mg/ml), T5 (42,82 mg/ml) dan T1 (31,68 mg/ml). Perbedaan dari masing–masing

SINTESIS PROTEIN MIKROBA DAN AKTIVITAS ...sampai terendah yaitu T2 (59,50 mg/ml), T3 (55,58 mg/ml), T4 (47,55 mg/ml), T5 (42,82 mg/ml) dan T1 (31,68 mg/ml). Perbedaan dari masing–masing

Accofil 48 MU/0.5 ml (0.96 mg/ml) solution for injection ... · Accofil® 48 MU/0.5 ml (0.96 mg/ml) solution for injection or infusion in pre-filled syringe filgrastim This medicine

Accofil 48 MU/0.5 ml (0.96 mg/ml) solution for injection ... · Accofil® 48 MU/0.5 ml (0.96 mg/ml) solution for injection or infusion in pre-filled syringe filgrastim This medicine

ANNEX I SUMMARY OF PRODUCT · PDF file100 mg single-use vial containing powder for concentrate for infusion solution delivers 5 mL of 20 mg/mL of trastuzumab emtansine after reconstitution

ANNEX I SUMMARY OF PRODUCT · PDF file100 mg single-use vial containing powder for concentrate for infusion solution delivers 5 mL of 20 mg/mL of trastuzumab emtansine after reconstitution

Fentanyl Decontamination Studies€¦ · Decon mass[mL]) Target mass (mg) Decon volume (mL) Sample pH Dilution Volume(mL) Expected Concentration (mg/mL) 2Observed Concentration (mg/mL)

Fentanyl Decontamination Studies€¦ · Decon mass[mL]) Target mass (mg) Decon volume (mL) Sample pH Dilution Volume(mL) Expected Concentration (mg/mL) 2Observed Concentration (mg/mL)

Erbitux 5 mg/mL Erbitux 5 mg/mL

Erbitux 5 mg/mL Erbitux 5 mg/mL

Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast ... · DMEM-F12 supplemented with 10% horse serum, 5 mg/mL insulin, 1 mg/mL cholera toxin, and 100 mg/mL EGFR, 5 mg/mL

Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast ... · DMEM-F12 supplemented with 10% horse serum, 5 mg/mL insulin, 1 mg/mL cholera toxin, and 100 mg/mL EGFR, 5 mg/mL

Fomicyt 40 mg/ml powder for solution for infusion ... · UK PAR Fomicyt 40 mg/ml powder for solution for infusion PL 15011/0014 1 . Fomicyt 40 mg/ml powder for solution for infusion

Fomicyt 40 mg/ml powder for solution for infusion ... · UK PAR Fomicyt 40 mg/ml powder for solution for infusion PL 15011/0014 1 . Fomicyt 40 mg/ml powder for solution for infusion

Medicaid-Approved Preferred Drug List Documents/FLFL_CAID_PDL.pdf · Reference. Notes. morphine oral solution 10 mg/5 ml, 20 mg/5 ml (4 mg/ml) QL. morphine oral tablet 15 mg, 30 mg.

Medicaid-Approved Preferred Drug List Documents/FLFL_CAID_PDL.pdf · Reference. Notes. morphine oral solution 10 mg/5 ml, 20 mg/5 ml (4 mg/ml) QL. morphine oral tablet 15 mg, 30 mg.

0.96 mg/ml

0.96 mg/ml